日本新薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/03/02 | 5,800 | 6,040 | 5,780 | 5,980 | +80 | +1.4% | 438,300 |
2018/03/01 | 5,960 | 5,960 | 5,860 | 5,900 | -120 | -2% | 308,300 |
2018/02/28 | 5,900 | 6,170 | 5,880 | 6,020 | +100 | +1.7% | 506,600 |
2018/02/27 | 6,030 | 6,030 | 5,820 | 5,920 | -50 | -0.8% | 485,100 |
2018/02/26 | 5,940 | 5,990 | 5,890 | 5,970 | +100 | +1.7% | 526,900 |
2018/02/23 | 5,870 | 5,920 | 5,800 | 5,870 | -40 | -0.7% | 651,500 |
2018/02/22 | 6,050 | 6,100 | 5,900 | 5,910 | -270 | -4.4% | 588,300 |
2018/02/21 | 6,200 | 6,280 | 5,980 | 6,180 | -110 | -1.7% | 620,100 |
2018/02/20 | 6,340 | 6,410 | 6,280 | 6,290 | -80 | -1.3% | 241,500 |
2018/02/19 | 6,280 | 6,400 | 6,260 | 6,370 | +120 | +1.9% | 212,100 |
2018/02/16 | 6,190 | 6,310 | 6,180 | 6,250 | +90 | +1.5% | 199,700 |
2018/02/15 | 6,080 | 6,210 | 6,080 | 6,160 | +100 | +1.7% | 304,000 |
2018/02/14 | 6,260 | 6,260 | 6,050 | 6,060 | -200 | -3.2% | 425,700 |
2018/02/13 | 6,420 | 6,430 | 6,230 | 6,260 | -130 | -2% | 414,400 |
2018/02/09 | 6,470 | 6,470 | 6,270 | 6,390 | -300 | -4.5% | 328,300 |
2018/02/08 | 6,750 | 6,780 | 6,650 | 6,690 | ±0 | ±0% | 292,000 |
2018/02/07 | 6,940 | 7,030 | 6,660 | 6,690 | -230 | -3.3% | 542,100 |
2018/02/06 | 6,960 | 7,000 | 6,760 | 6,920 | -440 | -6% | 334,500 |
2018/02/05 | 7,460 | 7,530 | 7,350 | 7,360 | -250 | -3.3% | 167,400 |
2018/02/02 | 7,600 | 7,640 | 7,530 | 7,610 | -20 | -0.3% | 222,300 |
2018/02/01 | 7,550 | 7,630 | 7,520 | 7,630 | +120 | +1.6% | 149,100 |
2018/01/31 | 7,580 | 7,670 | 7,510 | 7,510 | -120 | -1.6% | 275,300 |
2018/01/30 | 7,710 | 7,770 | 7,600 | 7,630 | -110 | -1.4% | 228,400 |
2018/01/29 | 7,800 | 7,870 | 7,720 | 7,740 | -60 | -0.8% | 181,900 |
2018/01/26 | 7,880 | 7,890 | 7,770 | 7,800 | +10 | +0.1% | 217,200 |
2018/01/25 | 7,900 | 7,950 | 7,760 | 7,790 | -70 | -0.9% | 219,500 |
2018/01/24 | 7,990 | 8,020 | 7,800 | 7,860 | -190 | -2.4% | 432,500 |
2018/01/23 | 8,100 | 8,120 | 8,030 | 8,050 | ±0 | ±0% | 189,800 |
2018/01/22 | 8,040 | 8,080 | 8,020 | 8,050 | -30 | -0.4% | 167,200 |
2018/01/19 | 8,020 | 8,150 | 8,020 | 8,080 | +70 | +0.9% | 171,000 |
2018/01/18 | 8,110 | 8,150 | 8,010 | 8,010 | -10 | -0.1% | 208,700 |
2018/01/17 | 8,050 | 8,190 | 8,000 | 8,020 | -160 | -2% | 276,100 |
2018/01/16 | 8,340 | 8,340 | 8,180 | 8,180 | -70 | -0.8% | 279,000 |
2018/01/15 | 8,260 | 8,300 | 8,230 | 8,250 | +90 | +1.1% | 112,100 |
2018/01/12 | 8,030 | 8,240 | 8,000 | 8,160 | +160 | +2% | 269,300 |
2018/01/11 | 8,340 | 8,390 | 7,880 | 8,000 | -490 | -5.8% | 619,800 |
2018/01/10 | 8,760 | 8,760 | 8,490 | 8,490 | -270 | -3.1% | 364,500 |
2018/01/09 | 8,630 | 8,820 | 8,620 | 8,760 | ±0 | ±0% | 167,500 |
2018/01/05 | 8,680 | 8,780 | 8,660 | 8,760 | +90 | +1% | 124,700 |
2018/01/04 | 8,500 | 8,680 | 8,450 | 8,670 | +260 | +3.1% | 142,200 |
2017/12/29 | 8,440 | 8,470 | 8,390 | 8,410 | ±0 | ±0% | 70,100 |
2017/12/28 | 8,400 | 8,500 | 8,370 | 8,410 | +10 | +0.1% | 105,900 |
2017/12/27 | 8,430 | 8,450 | 8,370 | 8,400 | -30 | -0.4% | 85,900 |
2017/12/26 | 8,430 | 8,520 | 8,410 | 8,430 | +20 | +0.2% | 86,100 |
2017/12/25 | 8,310 | 8,480 | 8,310 | 8,410 | +140 | +1.7% | 127,000 |
2017/12/22 | 8,130 | 8,330 | 8,110 | 8,270 | +160 | +2% | 158,700 |
2017/12/21 | 8,060 | 8,130 | 8,040 | 8,110 | ±0 | ±0% | 147,800 |
2017/12/20 | 8,210 | 8,320 | 8,070 | 8,110 | -120 | -1.5% | 190,100 |
2017/12/19 | 8,380 | 8,380 | 8,220 | 8,230 | -150 | -1.8% | 97,100 |
2017/12/18 | 8,280 | 8,430 | 8,230 | 8,380 | +180 | +2.2% | 162,300 |
1751~
1800
件表示中 / 3693件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日本新薬 | 348,400円 | +7.9% | +8.9% | 3.56% | 7.45倍 | 1.00倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ツムラ | 432,700円 | +20.9% | +87.3% | 3.14% | 9.66倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
ペプチド | 190,600円 | +5.0% | +1.5% | 0.00% | 16.36倍 | 4.35倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サワイGHD | 201,600円 | +4.0% | +25.4% | 2.63% | 8.82倍 | 1.16倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
科研薬 | 405,500円 | +30.5% | +111.0% | 4.69% | 11.43倍 | 0.99倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム